176 related articles for article (PubMed ID: 21186794)
1. α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.
Bazzaro M; Anchoori RK; Mudiam MK; Issaenko O; Kumar S; Karanam B; Lin Z; Isaksson Vogel R; Gavioli R; Destro F; Ferretti V; Roden RB; Khan SR
J Med Chem; 2011 Jan; 54(2):449-56. PubMed ID: 21186794
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
3. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
4. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
Anchoori RK; Khan SR; Sueblinvong T; Felthauser A; Iizuka Y; Gavioli R; Destro F; Isaksson Vogel R; Peng S; Roden RB; Bazzaro M
PLoS One; 2011; 6(8):e23888. PubMed ID: 21909374
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
[TBL] [Abstract][Full Text] [Related]
6. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
7. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome.
Achanta G; Modzelewska A; Feng L; Khan SR; Huang P
Mol Pharmacol; 2006 Jul; 70(1):426-33. PubMed ID: 16636137
[TBL] [Abstract][Full Text] [Related]
8. Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes.
Issaenko OA; Amerik AY
Cell Cycle; 2012 May; 11(9):1804-17. PubMed ID: 22510564
[TBL] [Abstract][Full Text] [Related]
9. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of polycyclic chalcone based acrylamides in human MCF-7 and HeLa cancer cell lines.
Gunasekaran V; Yuvakkumar R; Ganesan R; Palapetta SC; Gurusamy H
Environ Res; 2023 Apr; 222():115395. PubMed ID: 36731601
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
Burmaoglu S; Gobek A; Aydin BO; Yurtoglu E; Aydin BN; Ozkat GY; Hepokur C; Ozek NS; Aysin F; Altundas R; Algul O
Bioorg Chem; 2021 Jun; 111():104882. PubMed ID: 33839582
[TBL] [Abstract][Full Text] [Related]
15. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
16. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
[TBL] [Abstract][Full Text] [Related]
20. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
